Essay About Nobel Laureate Dr. Eric Kandel And Target Markets

Memory Pharmaceuticals Corp
Essay title: Memory Pharmaceuticals Corp
„Memory Pharmaceuticals Corp.“
Final
Marketing Management
-Dr. Steve Henson-
Nihat Canak
03/28/2006
Index of contents
Executive Summary
Situation Analysis
Market Summary
2.1.1
Market Demographics
2.1.2
Market Needs
2.1.3
Market Trends and Growth
SWOT Analysis
2.2.1
Strengths
2.2.2
Weaknesses
2.2.3
Opportunities
2.2.4
Threats
Competition
Keys to Success
Critical Issues
Marketing Strategy
Mission
Marketing Objectives
Financial Objectives
Target Markets
Positioning
Strategy Pyramids
Marketing Mix
Marketing Research
Financials
Break-even Analysis
Sales Forecast
Expense Forecast
Controls
Marketing Organization
Contingency Planning
Bibliographies
Exhibit
Executive Summary
Memory Pharmaceuticals Corp. (MP), incorporated in 1997, is a biopharmaceutical company focused on the development of innovative drug candidates for the treatment of a broad range of CNS conditions that exhibit significant impairment of memory and other cognitive functions. These conditions include neurological diseases associated with aging, such as Alzheimer’s disease, and also include certain psychiatric disorders such as schizophrenia, bipolar disorder and depression. Through pioneering research conducted over more than 30 years, Nobel Laureate Dr. Eric Kandel, one of MP’s scientific founders, identified critical cellular pathways and biological targets involved in memory formation. This research, which was published in the 1990s, served as the cornerstone